vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and Information Services Group Inc. (III). Click either name above to swap in a different company.
Information Services Group Inc. is the larger business by last-quarter revenue ($61.2M vs $44.9M, roughly 1.4× AbCellera Biologics Inc.). Information Services Group Inc. runs the higher net margin — 4.3% vs -19.9%, a 24.2% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 5.9%). Information Services Group Inc. produced more free cash flow last quarter ($4.3M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs -2.4%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
EBSCO Information Services, headquartered in Ipswich, Massachusetts, is a division of EBSCO Industries Inc., a private company headquartered in Birmingham, Alabama. EBSCO provides products and services to libraries of many types around the world. Its products include EBSCONET, a complete e-resource management system, and EBSCOhost, which supplies a fee-based online research service with 375 full-text databases, a collection of 600,000-plus ebooks, subject indexes, point-of-care medical refere...
ABCL vs III — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $61.2M |
| Net Profit | $-8.9M | $2.6M |
| Gross Margin | — | 44.8% |
| Operating Margin | -63.7% | 8.4% |
| Net Margin | -19.9% | 4.3% |
| Revenue YoY | 788.4% | 5.9% |
| Net Profit YoY | 73.9% | -14.1% |
| EPS (diluted) | $-0.03 | $0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $61.2M | ||
| Q3 25 | $9.0M | $62.4M | ||
| Q2 25 | $17.1M | $61.6M | ||
| Q1 25 | $4.2M | $59.6M | ||
| Q4 24 | $5.0M | $57.8M | ||
| Q3 24 | $6.5M | $61.3M | ||
| Q2 24 | $7.3M | $64.3M | ||
| Q1 24 | $10.0M | $64.3M |
| Q4 25 | $-8.9M | $2.6M | ||
| Q3 25 | $-57.1M | $3.1M | ||
| Q2 25 | $-34.7M | $2.2M | ||
| Q1 25 | $-45.6M | $1.5M | ||
| Q4 24 | — | $3.0M | ||
| Q3 24 | $-51.1M | $1.1M | ||
| Q2 24 | $-36.9M | $2.0M | ||
| Q1 24 | $-40.6M | $-3.4M |
| Q4 25 | — | 44.8% | ||
| Q3 25 | — | 42.2% | ||
| Q2 25 | — | 42.2% | ||
| Q1 25 | — | 43.1% | ||
| Q4 24 | — | 41.5% | ||
| Q3 24 | — | 40.4% | ||
| Q2 24 | — | 39.5% | ||
| Q1 24 | — | 36.1% |
| Q4 25 | -63.7% | 8.4% | ||
| Q3 25 | -851.8% | 7.4% | ||
| Q2 25 | -290.2% | 7.6% | ||
| Q1 25 | -1479.6% | 5.7% | ||
| Q4 24 | — | 0.3% | ||
| Q3 24 | -1439.4% | 7.0% | ||
| Q2 24 | -1276.2% | 5.7% | ||
| Q1 24 | -551.5% | -3.7% |
| Q4 25 | -19.9% | 4.3% | ||
| Q3 25 | -637.8% | 4.9% | ||
| Q2 25 | -203.3% | 3.5% | ||
| Q1 25 | -1077.2% | 2.5% | ||
| Q4 24 | — | 5.3% | ||
| Q3 24 | -785.4% | 1.9% | ||
| Q2 24 | -504.3% | 3.2% | ||
| Q1 24 | -408.0% | -5.3% |
| Q4 25 | $-0.03 | $0.06 | ||
| Q3 25 | $-0.19 | $0.06 | ||
| Q2 25 | $-0.12 | $0.04 | ||
| Q1 25 | $-0.15 | $0.03 | ||
| Q4 24 | — | $0.07 | ||
| Q3 24 | $-0.17 | $0.02 | ||
| Q2 24 | $-0.13 | $0.04 | ||
| Q1 24 | $-0.14 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $28.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $966.9M | $94.7M |
| Total Assets | $1.4B | $211.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | $28.7M | ||
| Q3 25 | $83.2M | $28.7M | ||
| Q2 25 | $92.4M | $25.2M | ||
| Q1 25 | $159.3M | $20.1M | ||
| Q4 24 | $156.3M | $23.1M | ||
| Q3 24 | $126.6M | $9.7M | ||
| Q2 24 | $148.3M | $11.8M | ||
| Q1 24 | $123.6M | $14.0M |
| Q4 25 | $966.9M | $94.7M | ||
| Q3 25 | $964.0M | $94.7M | ||
| Q2 25 | $1.0B | $94.1M | ||
| Q1 25 | $1.0B | $95.0M | ||
| Q4 24 | $1.1B | $96.3M | ||
| Q3 24 | $1.1B | $96.6M | ||
| Q2 24 | $1.1B | $95.5M | ||
| Q1 24 | $1.1B | $95.6M |
| Q4 25 | $1.4B | $211.0M | ||
| Q3 25 | $1.4B | $213.3M | ||
| Q2 25 | $1.4B | $200.7M | ||
| Q1 25 | $1.3B | $202.4M | ||
| Q4 24 | $1.4B | $204.5M | ||
| Q3 24 | $1.4B | $227.1M | ||
| Q2 24 | $1.4B | $235.3M | ||
| Q1 24 | $1.5B | $234.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $5.1M |
| Free Cash FlowOCF − Capex | $-44.6M | $4.3M |
| FCF MarginFCF / Revenue | -99.4% | 7.0% |
| Capex IntensityCapex / Revenue | 21.9% | 1.2% |
| Cash ConversionOCF / Net Profit | — | 1.94× |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $25.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $5.1M | ||
| Q3 25 | $-52.6M | $11.1M | ||
| Q2 25 | $-32.4M | $11.9M | ||
| Q1 25 | $-11.6M | $978.0K | ||
| Q4 24 | $-108.6M | $6.6M | ||
| Q3 24 | $-28.9M | $8.8M | ||
| Q2 24 | $-30.0M | $2.2M | ||
| Q1 24 | $-41.7M | $2.3M |
| Q4 25 | $-44.6M | $4.3M | ||
| Q3 25 | $-61.5M | $9.5M | ||
| Q2 25 | $-45.8M | $11.1M | ||
| Q1 25 | $-22.2M | $141.0K | ||
| Q4 24 | $-187.0M | $6.0M | ||
| Q3 24 | $-47.4M | $8.4M | ||
| Q2 24 | $-50.1M | $1.3M | ||
| Q1 24 | $-65.8M | $1.3M |
| Q4 25 | -99.4% | 7.0% | ||
| Q3 25 | -687.0% | 15.2% | ||
| Q2 25 | -267.9% | 18.0% | ||
| Q1 25 | -524.0% | 0.2% | ||
| Q4 24 | -3702.8% | 10.4% | ||
| Q3 24 | -728.4% | 13.7% | ||
| Q2 24 | -683.8% | 2.0% | ||
| Q1 24 | -661.5% | 2.0% |
| Q4 25 | 21.9% | 1.2% | ||
| Q3 25 | 99.7% | 2.5% | ||
| Q2 25 | 78.2% | 1.4% | ||
| Q1 25 | 251.1% | 1.4% | ||
| Q4 24 | 1552.7% | 0.9% | ||
| Q3 24 | 284.6% | 0.6% | ||
| Q2 24 | 274.6% | 1.4% | ||
| Q1 24 | 242.5% | 1.6% |
| Q4 25 | — | 1.94× | ||
| Q3 25 | — | 3.62× | ||
| Q2 25 | — | 5.46× | ||
| Q1 25 | — | 0.66× | ||
| Q4 24 | — | 2.15× | ||
| Q3 24 | — | 7.66× | ||
| Q2 24 | — | 1.07× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
